Cargando…
Programmed death ligand 1 regulates epithelial–mesenchymal transition and cancer stem cell phenotypes in hepatocellular carcinoma through the serum and glucocorticoid kinase 2/β‐catenin signaling pathway
Programmed death ligand 1 (PD‐L1) plays an important role in the occurrence of hepatocellular carcinoma (HCC). The present study indicated that epithelial–mesenchymal transition (EMT) and induction of cancer stem cell (CSC)‐like properties contribute to metastasis of cancers. However, the molecular...
Autores principales: | Kong, Xin, Peng, Hong, Liu, Peng, Fu, Xiao, Wang, Ni, Zhang, Dazhi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10236605/ https://www.ncbi.nlm.nih.gov/pubmed/36751987 http://dx.doi.org/10.1111/cas.15753 |
Ejemplares similares
-
Janus kinase 3 regulates adherens junctions and epithelial mesenchymal transition through β-catenin
por: Mishra, Jayshree, et al.
Publicado: (2017) -
Prognostic significance of programmed cell death-ligand 1 expression on immune cells and epithelial-mesenchymal transition expression in patients with hepatocellular carcinoma
por: Jung, Hae Il, et al.
Publicado: (2023) -
ARHGEF11 promotes proliferation and epithelial-mesenchymal transition of hepatocellular carcinoma through activation of β-catenin pathway
por: Du, Jinpeng, et al.
Publicado: (2020) -
IGFBP2 drives epithelial-mesenchymal transition in hepatocellular carcinoma via activating the Wnt/β-catenin pathway
por: Chen, Xiu, et al.
Publicado: (2023) -
Metadherin Promotes Malignant Phenotypes And Induces Beta-Catenin Nuclear Translocation And Epithelial–Mesenchymal Transition In Gastric Cancer
por: Feng, Di, et al.
Publicado: (2019)